MORRISVILLE, N.C., Oct. 4, 2013 /PRNewswire/ -- Gentris Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today that Gentris founder, Michael Murphy, and leading cancer pharmacogenomics expert, Dr. Howard McLeod, have joined the......
More...







